90 related articles for article (PubMed ID: 15605596)
1. Diclofenac release from eudragit-containing matrices and effects of thermal treatment.
Billa N; Yuen KH; Peh KK
Drug Dev Ind Pharm; 1998 Jan; 24(1):45-50. PubMed ID: 15605596
[TBL] [Abstract][Full Text] [Related]
2. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
3. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
4. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
5. Eudragit E as excipient for production of granules and tablets from Phyllanthus niruri L spray-dried extract.
Pereira de Souza T; Martínez-Pacheco R; Gómez-Amoza JL; Petrovick PR
AAPS PharmSciTech; 2007 Apr; 8(2):Article 34. PubMed ID: 17622112
[TBL] [Abstract][Full Text] [Related]
6. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
[TBL] [Abstract][Full Text] [Related]
7. Mechanical properties of excipients do not affect polymer matrix formation.
Chatterjee L; Rades T; Tucker IG
Int J Pharm; 2010 Jan; 384(1-2):87-92. PubMed ID: 19819317
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.
Azarmi S; Ghaffari F; Löbenberg R; Nokhodchi A
Farmaco; 2005; 60(11-12):925-30. PubMed ID: 16223498
[TBL] [Abstract][Full Text] [Related]
9. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
[TBL] [Abstract][Full Text] [Related]
10. Individual and interacting effects of formulation variables on the tensile strength and microbial survival in diclofenac tablets.
Ayorinde JO; Itiola OA
Arch Pharm Res; 2010 Mar; 33(3):395-403. PubMed ID: 20361304
[TBL] [Abstract][Full Text] [Related]
11. Particle size distribution and evolution in tablet structure during and after compaction.
Fichtner F; Rasmuson A; Alderborn G
Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
13. Influence of methacrylic acid and hydroxypropylmethyl cellulose on the tablet properties and in vitro release of dextromethorphan hydrobromide.
Takka S; Singh Bharaj S; Sakr A
Pharmazie; 2003 Dec; 58(12):886-90. PubMed ID: 14703967
[TBL] [Abstract][Full Text] [Related]
14. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
15. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices.
Azarmi S; Farid J; Nokhodchi A; Bahari-Saravi SM; Valizadeh H
Int J Pharm; 2002 Oct; 246(1-2):171-7. PubMed ID: 12270619
[TBL] [Abstract][Full Text] [Related]
16. Drug release control and system understanding of sucrose esters matrix tablets by artificial neural networks.
Chansanroj K; Petrović J; Ibrić S; Betz G
Eur J Pharm Sci; 2011 Oct; 44(3):321-31. PubMed ID: 21878388
[TBL] [Abstract][Full Text] [Related]
17. The influence of thermal treatment on the release behavior of diclofenac sodium from acrylic matrices.
Azarmi S; Farid D; Azodi-Deylami S; Ghaffari F; Nokhodchi A
Pharm Dev Technol; 2005; 10(2):233-9. PubMed ID: 15926672
[TBL] [Abstract][Full Text] [Related]
18. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium.
Al-Taani BM; Tashtoush BM
AAPS PharmSciTech; 2003; 4(3):E43. PubMed ID: 14621975
[TBL] [Abstract][Full Text] [Related]
19. Novel application of hot-melt extrusion for the preparation of monolithic matrices containing enteric-coated particles.
Schilling SU; McGinity JW
Int J Pharm; 2010 Nov; 400(1-2):24-31. PubMed ID: 20727956
[TBL] [Abstract][Full Text] [Related]
20. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
Leopold CS; Eikeler D
J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
